These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 7978802)
1. Matrix metalloproteinase-9 in tumor cell invasion. French DL; Ramos-DeSimone N; Rozinski K; Nuovo GJ Ann N Y Acad Sci; 1994 Sep; 732():324-34. PubMed ID: 7978802 [No Abstract] [Full Text] [Related]
2. Monoclonal antibodies to human MMP-9. Ramos-DeSimone N; French DL Ann N Y Acad Sci; 1994 Sep; 732():469-71. PubMed ID: 7978841 [No Abstract] [Full Text] [Related]
3. Gelatinases/type IV collagenases in jaw cyst expansion. Teronen O; Salo T; Konttinen YT; Rifkin B; Vernillo A; Ramamurthy NS; Kjeldsen L; Borregaard N; Sommerhoff CP; Sorsa T Ann N Y Acad Sci; 1994 Sep; 732():486-8. PubMed ID: 7978847 [No Abstract] [Full Text] [Related]
5. Cumulative influence of elastin peptides and plasminogen on matrix metalloproteinase activation and type I collagen invasion by HT-1080 fibrosarcoma cells. Huet E; Brassart B; Cauchard JH; Debelle L; Birembaut P; Wallach J; Emonard H; Polette M; Hornebeck W Clin Exp Metastasis; 2002; 19(2):107-17. PubMed ID: 11964074 [TBL] [Abstract][Full Text] [Related]
6. Matrix metalloproteinases in sterile corneal melts. Geerling G; Joussen AM; Daniels JT; Mulholland B; Khaw PT; Dart JK Ann N Y Acad Sci; 1999 Jun; 878():571-4. PubMed ID: 10415776 [No Abstract] [Full Text] [Related]
7. Activation of tumor cell matrix metalloproteinase-2 by neutrophil proteinases requires expression of membrane-type 1 matrix metalloproteinase. Schwartz JD; Shamamian P; Monea S; Whiting D; Marcus SG; Galloway AC; Mignatti P Surgery; 1998 Aug; 124(2):232-8. PubMed ID: 9706143 [TBL] [Abstract][Full Text] [Related]
8. Enhancement of type IV collagenases by highly metastatic variants of HT1080 fibrosarcoma cells established by a transendothelial invasion system in vitro. Okada T; Li J; Kodaka M; Okuno H Clin Exp Metastasis; 1998 Apr; 16(3):267-74. PubMed ID: 9568644 [TBL] [Abstract][Full Text] [Related]
9. Tumor cell invasion through matrigel is regulated by activated matrix metalloproteinase-2. Deryugina EI; Luo GX; Reisfeld RA; Bourdon MA; Strongin A Anticancer Res; 1997; 17(5A):3201-10. PubMed ID: 9413149 [TBL] [Abstract][Full Text] [Related]
10. Comparative analysis of matrix metalloproteinases by immunocytochemistry, immunohistochemistry and zymography in human primary brain tumours. Rooprai HK; Van Meter T; Rucklidge GJ; Hudson L; Everall IP; Pilkington GJ Int J Oncol; 1998 Dec; 13(6):1153-7. PubMed ID: 9824624 [TBL] [Abstract][Full Text] [Related]
11. HIV-1 modulates the expression of gelatinase A and B in monocytic cells. Kalebic T; Masiero L; Onisto M; Garbisa S Biochem Biophys Res Commun; 1994 Dec; 205(2):1243-9. PubMed ID: 7802656 [TBL] [Abstract][Full Text] [Related]
12. Levels of matrix metalloproteases in bladder cancer correlate with tumor grade and invasion. Davies B; Waxman J; Wasan H; Abel P; Williams G; Krausz T; Neal D; Thomas D; Hanby A; Balkwill F Cancer Res; 1993 Nov; 53(22):5365-9. PubMed ID: 8221672 [TBL] [Abstract][Full Text] [Related]
13. A study of metalloproteinases in fifty joint fluid specimens. Gaudin P; Razakaboay M; Surla A; Berthier S; Fauconnier J; Morel F; Phelip X Rev Rhum Engl Ed; 1997 Jun; 64(6):375-81. PubMed ID: 9513609 [TBL] [Abstract][Full Text] [Related]
14. Induction of matrix metalloproteinase activation cascades based on membrane-type 1 matrix metalloproteinase: associated activation of gelatinase A, gelatinase B and collagenase 3. Cowell S; Knäuper V; Stewart ML; D'Ortho MP; Stanton H; Hembry RM; López-Otín C; Reynolds JJ; Murphy G Biochem J; 1998 Apr; 331 ( Pt 2)(Pt 2):453-8. PubMed ID: 9531484 [TBL] [Abstract][Full Text] [Related]
15. Characterization of an endogenous metalloproteinase in human vitreous. Brown D; Hamdi H; Bahri S; Kenney MC Curr Eye Res; 1994 Sep; 13(9):639-47. PubMed ID: 7805394 [TBL] [Abstract][Full Text] [Related]
16. 92K-GL (MMP-9) and 72K-GL (MMP-2) are produced in vivo by human oral squamous cell carcinomas and can enhance FIB-CL (MMP-1) activity in vitro. Pickett KL; Harber GJ; DeCarlo AA; Louis P; Shaneyfelt S; Windsor LJ; Bodden MK J Dent Res; 1999 Jul; 78(7):1354-61. PubMed ID: 10403463 [TBL] [Abstract][Full Text] [Related]
17. Anti-invasive activity of ursolic acid correlates with the reduced expression of matrix metalloproteinase-9 (MMP-9) in HT1080 human fibrosarcoma cells. Cha HJ; Bae SK; Lee HY; Lee OH; Sato H; Seiki M; Park BC; Kim KW Cancer Res; 1996 May; 56(10):2281-4. PubMed ID: 8625299 [TBL] [Abstract][Full Text] [Related]